Sue Cammarata, Chief Medical Officer at MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), bought 4,000 shares at $5.00 ($20K) on 2018-05-29, disclosed to the SEC on 2018-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.